Margo Monroe and Mandeep Kaur will speak on the panel, “IP Findings That Change Valuation,” at the Oncology Venture, Innovation & Partnering Summit on Tuesday, October 20, 2026. Their session, “What Oncology Companies Need to Know About Diligence, Clinical Trials, and Exclusivity,” will explore how patent diligence, clinical trial disclosures, and global development strategies can impact exclusivity, valuation, financing, and IPO readiness. While intellectual property issues do not often derail transactions, they can significantly influence deal value, making a thorough understanding of these considerations critical for oncology companies, investors, and strategic partners. The Oncology Venture, Innovation & Partnering Summit brings together investors, corporate executives, entrepreneurs, and industry leaders focused on advancing cancer innovation. Please visit the Oncology VIP website for more information and to register for the Summit. LEARN MORE